Researcher.Life Logo

Cancer Biology and Medicine : Impact Factor & More

eISSN: 2095-3941pISSN: 2095-3941
JournalOpen Access

Key Metrics

CiteScore
6.5
SNIP
1.13
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancer Biology and Medicine

Cancer Biology and Medicine Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher CHINA ANTI-CANCER ASSOC
Language English
Frequency Quarterly
Article Processing ChargesUSD 1500
Publication Time12
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2012
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 12
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Cancer Biology and Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Biology and Medicine

Erratum to PGK1-coupled HSP90 stabilizes GSK3β expression to regulate the stemness of breast cancer stem cells.
  • 27 Jun 2026
  • Cancer biology & medicine
Less is more: patients with cervical cancer benefit from de-escalated chemotherapy plus immuno-targeted therapies.
  • 22 Jun 2026
  • Cancer biology & medicine
Thermal ablation versus loop electrosurgical excision procedure and cold knife conization for cervical intraepithelial neoplasia: efficacy and HPV clearance in a 5-year cohort of Chinese women.
  • 5 Jun 2026
  • Cancer biology & medicine
Toward the precision use of Chinese PARP inhibitors in ovarian cancer: clinical progress, resistance mechanisms, and future perspectives.
  • 1 Jun 2026
  • Cancer biology & medicine
Comprehensive microbiome profiling reveals mucosal microbiome heterogeneity in patients with left- and right-sided colorectal neoplasia.
  • 26 May 2026
  • Cancer biology & medicine
Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer: a prospective, multicenter, non-interventional study (FLOURISH).
  • 21 May 2026
  • Cancer biology & medicine
Erratum to PGK1-coupled HSP90 stabilizes GSK3β expression to regulate the stemness of breast cancer stem cells.
  • 27 Jun 2026
  • Cancer biology & medicine
Less is more: patients with cervical cancer benefit from de-escalated chemotherapy plus immuno-targeted therapies.
  • 22 Jun 2026
  • Cancer biology & medicine
Thermal ablation versus loop electrosurgical excision procedure and cold knife conization for cervical intraepithelial neoplasia: efficacy and HPV clearance in a 5-year cohort of Chinese women.
  • 5 Jun 2026
  • Cancer biology & medicine
Toward the precision use of Chinese PARP inhibitors in ovarian cancer: clinical progress, resistance mechanisms, and future perspectives.
  • 1 Jun 2026
  • Cancer biology & medicine
Comprehensive microbiome profiling reveals mucosal microbiome heterogeneity in patients with left- and right-sided colorectal neoplasia.
  • 26 May 2026
  • Cancer biology & medicine
Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer: a prospective, multicenter, non-interventional study (FLOURISH).
  • 21 May 2026
  • Cancer biology & medicine

FAQs on Cancer Biology and Medicine